副甲状腺癌的基本临床分析
Lucas Fuenzalida1,2,3, Sebastián Indo3,4, Héctor R Contreras3,4,5
1Doctorate in Medical Sciences and Clinical Specialty Program, Postgraduate School, Faculty of Medicine, University of Chile, Santiago 8320328, Chile.
Biomedicines
|March 28, 2025
概括
诊断副甲状腺癌 (PC) 是一个挑战. 本综述探讨了新型生物标志物,包括表皮-介质细胞过渡和表观遗传标志物,以改善PC诊断并将其与良性腺瘤区分开来.
科学领域:
- 内分泌学 在内分泌学.
- 在瘤学瘤学.
- 病理学 病理学 病理学
背景情况:
- 甲状腺癌 (PC) 诊断是复杂的,通常依赖于侵入性的术后活检标准.
- 临床表现包括副甲状腺功能障碍和局部压缩症状.
- 目前的诊断方法缺乏明确的早期指标,需要生物标志物研究.
研究的目的:
- 审查目前对甲状腺癌的临床方法.
- 分析PC的诊断生物标志物的最新情况.
- 预测PC生物标志物发现的未来方向.
主要方法:
- 文献综述侧重于免疫组织化学,表皮-介质细胞过渡标记,癌症干细胞标记,瘤基因,瘤抑制基因和表观遗传标记 (miRNAs, lncRNAs, circRNAs).
- 对PC诊断相关的蛋白质和炎症标志物的分析.
- 对PC生物标志物的临床和基础科学研究的综合.
主要成果:
- 像上皮层-介质细胞过渡和癌症干细胞标志物这样的生物标志物在区分甲状腺腺瘤和癌症方面尚未得到充分研究.
- 表观遗传标记物 (miRNAs, lncRNAs, circRNAs),瘤基因和瘤抑制基因显示出作为诊断工具的巨大潜力.
- 蛋白质和炎症标志物也被确定为副甲状腺癌的潜在诊断辅助物.
结论:
- 新型生物标志物对于提高副甲状腺癌诊断的准确性和及时性至关重要.
- 对这些标记物的进一步研究可能会导致良性和恶性副甲状腺疾病之间的更好的歧视.
- 生物标志物发现的进步有望改善状腺癌的诊断策略和患者的治疗结果.
相关概念视频
00:59The Parathyroid Glands
5.2K
The two pairs of parathyroid glands embedded within the posterior surface of the thyroid gland are restricted by a dense capsule around them. These glands comprise two distinct cell populations—parathyroid oxyphil and parathyroid principal cells- pivotal in calcium homeostasis.
Oxyphil cells, whose functions remain elusive, emerge during late puberty, adding a layer of complexity to the parathyroid gland's intricacies. In contrast, principal parathyroid cells undertake a vital role by...
Oxyphil cells, whose functions remain elusive, emerge during late puberty, adding a layer of complexity to the parathyroid gland's intricacies. In contrast, principal parathyroid cells undertake a vital role by...
5.2K
01:21Cancer Survival Analysis
870
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
870
01:27Hyperthyroidism II: Pathophysiology
36
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH...
36